New obesity drug combo shows promise in Mid-Stage trial
Disease control
Ongoing
This study tests a new injectable drug called nimacimab, given weekly, to see if it helps overweight or obese adults lose weight. Some participants will receive nimacimab alone, others will get it together with semaglutide (a known weight-loss drug), and some will receive a place…
Phase: PHASE2 • Sponsor: Skye Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC